These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 28286967)

  • 1. Protective effect of glucagon-like peptide-1 agents on reperfusion injury for acute myocardial infarction: a meta-analysis of randomized controlled trials.
    Huang M; Wei R; Wang Y; Su T; Li Q; Yang X; Chen X
    Ann Med; 2017 Nov; 49(7):552-561. PubMed ID: 28286967
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of glucagon-like peptide-1 agonist in patients undergoing percutaneous coronary intervention or coronary artery bypass grafting: A meta-analysis.
    Ogbu IR; Ngwudike C; Lal K; Danielian A; Daoud SN
    Am Heart J Plus; 2021 Nov; 11():100063. PubMed ID: 38549742
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of glucagon-like peptide-1 in patients with acute myocardial infarction and left ventricular dysfunction after successful reperfusion.
    Nikolaidis LA; Mankad S; Sokos GG; Miske G; Shah A; Elahi D; Shannon RP
    Circulation; 2004 Mar; 109(8):962-5. PubMed ID: 14981009
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and efficacy of intracoronary adenosine administration in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention: a meta-analysis of randomized controlled trials.
    Singh M; Shah T; Khosla K; Singh P; Molnar J; Khosla S; Arora R
    Ther Adv Cardiovasc Dis; 2012 Jun; 6(3):101-14. PubMed ID: 22562999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Erythropoietin treatment in patients with acute myocardial infarction: a meta-analysis of randomized controlled trials.
    Gao D; Ning N; Niu X; Dang Y; Dong X; Wei J; Zhu C
    Am Heart J; 2012 Nov; 164(5):715-727.e1. PubMed ID: 23137502
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of Glucagon-Like Peptide-1 Receptor Agonist (GLP-1RA) on Cardiac Structure and Function: A Systematic Review and Meta-Analysis of Randomized-Controlled Trials.
    Wong SY; Lee ARYB; Sia AHJ; Wo YJ; Teo YH; Teo YN; Syn NL; Ong CC; Teo LL; Yeo TC; Poh KK; Kong WK; Wong RC; Sia CH
    Cardiovasc Drugs Ther; 2024 Apr; 38(2):371-389. PubMed ID: 35819544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness and tolerability of administration of granulocyte colony-stimulating factor on left ventricular function in patients with myocardial infarction: a meta-analysis of randomized controlled trials.
    Kang S; Yang Y; Li CJ; Gao R
    Clin Ther; 2007 Nov; 29(11):2406-18. PubMed ID: 18158081
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nicorandil in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention: a systematic review and meta-analysis.
    Wu M; Huang Z; Xie H; Zhou Z
    PLoS One; 2013; 8(10):e78231. PubMed ID: 24167609
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of Adenosine in Patients With Acute Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention: A PRISMA-Compliant Meta-Analysis.
    Gao Q; Yang B; Guo Y; Zheng F
    Medicine (Baltimore); 2015 Aug; 94(32):e1279. PubMed ID: 26266362
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Usefulness of Glucagon-Like Peptide-1 Receptor Agonists to Reduce Adverse Cardiovascular Disease Events in Patients with Type 2 Diabetes Mellitus.
    Grewal S; Zaman N; Borgatta L; Nudy M; Foy AJ; Peterson B
    Am J Cardiol; 2021 Sep; 154():48-53. PubMed ID: 34266665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Update in Cardiovascular Safety of Glucagon Like Peptide-1 Receptor Agonists in Patients With Type 2 Diabetes. A Mixed Treatment Comparison Meta-Analysis of Randomised Controlled Trials.
    Al Yami MS; Alfayez OM; Alsheikh R
    Heart Lung Circ; 2018 Nov; 27(11):1301-1309. PubMed ID: 29887418
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of aspiration and mechanical thrombectomy in patients with acute myocardial infarction undergoing primary angioplasty: an updated meta-analysis of randomized trials.
    Kumbhani DJ; Bavry AA; Desai MY; Bangalore S; Bhatt DL
    J Am Coll Cardiol; 2013 Oct; 62(16):1409-18. PubMed ID: 23665372
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of Glucagon-Like Peptide 1 Loading on periprocedural myocardial infarction During elective PCI (GOLD-PCI study): A randomized, placebo-controlled trial.
    Giblett JP; Clarke S; Zhao T; McCormick LM; Braganza DM; Densem CG; O'Sullivan M; Adlam D; Clarke SC; Steele J; Fielding S; West NEJ; Villar SS; Hoole SP
    Am Heart J; 2019 Sep; 215():41-51. PubMed ID: 31277053
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of glucagon-like peptide-1 receptor agonists on mortality and cardiovascular events: A comprehensive meta-analysis of randomized controlled trials.
    Monami M; Zannoni S; Pala L; Silverii A; Andreozzi F; Sesti G; Mannucci E
    Int J Cardiol; 2017 Aug; 240():414-421. PubMed ID: 28501352
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Postconditioning in patients treated with primary percutaneous coronary intervention: an updated meta-analysis.
    Wang L; Wang J; Xu H; Li B
    Catheter Cardiovasc Interv; 2013 Nov; 82(5):E662-71. PubMed ID: 23804529
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of nicorandil in patients with acute myocardial infarction undergoing percutaneous coronary intervention: a systematic review and meta-analysis.
    Ji Z; Zhang R; Lu W; Ma G; Qu Y
    Ir J Med Sci; 2020 Feb; 189(1):119-131. PubMed ID: 31147987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardioprotective effects of exenatide in patients with ST-segment-elevation myocardial infarction undergoing primary percutaneous coronary intervention: results of exenatide myocardial protection in revascularization study.
    Woo JS; Kim W; Ha SJ; Kim JB; Kim SJ; Kim WS; Seon HJ; Kim KS
    Arterioscler Thromb Vasc Biol; 2013 Sep; 33(9):2252-60. PubMed ID: 23868944
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized, double-blind, placebo-controlled study of the safety and efficacy of intravenous MCC-135 as an adjunct to primary percutaneous coronary intervention in patients with acute myocardial infarction: Evaluation of MCC-135 for left ventricular salvage in acute myocardial infarction (EVOLVE).
    Jang IK; Weissman NJ; Picard MH; Zile MR; Pettigrew V; Shen S; Tatsuno J; Hibberd MG; Tzivoni D; Wackers FJ;
    Am Heart J; 2008 Jan; 155(1):113.e1-8. PubMed ID: 18082500
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of intracoronary cell therapy on left ventricular function in the setting of acute myocardial infarction: a meta-analysis of randomised controlled clinical trials.
    Delewi R; Andriessen A; Tijssen JG; Zijlstra F; Piek JJ; Hirsch A
    Heart; 2013 Feb; 99(4):225-32. PubMed ID: 22875736
    [TBL] [Abstract][Full Text] [Related]  

  • 20. No benefit of additional treatment with exenatide in patients with an acute myocardial infarction.
    Roos ST; Timmers L; Biesbroek PS; Nijveldt R; Kamp O; van Rossum AC; van Hout GP; Stella PR; Doevendans PA; Knaapen P; Velthuis BK; van Royen N; Voskuil M; Nap A; Appelman Y
    Int J Cardiol; 2016 Oct; 220():809-14. PubMed ID: 27394978
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.